Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

An Update on Promising Agents against COVID-19: Secondary Metabolites and Mechanistic Aspects

Author(s): Maryam Jamshidnia, Robert D.E. Sewell and Mahmoud Rafieian-Kopaei*

Volume 28, Issue 29, 2022

Published on: 25 August, 2022

Page: [2415 - 2425] Pages: 11

DOI: 10.2174/1381612828666220722124826

Price: $65

Abstract

Background: Coronavirus disease 2019 (COVID‑19) is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and is associated with a high level of mortality.

Objective: This updated review aims to present the most important traditional medicinal plants and some of their secondary metabolites that have previously and more recently been shown to affect viruses and may represent a beneficial contributory step against SARS-CoV-2 as the cause of COVID-19. Moreover, the mechanism aspects of these secondary metabolites were discussed, which may help find more reliable drugs against SARSCoV- 2.

Methods: Articles were searched on scientific websites including Google Scholar, Scopus, Web of Science, PubMed, and IranMedex using the search terms herbal medicine and traditional medicine with coronavirus, SARS-CoV-2, or COVID-19. Human, animal, and in vitro studies were identified in the search.

Results: Medicinal plants and their secondary metabolites may possess a potential role in combating this disease, and researchers suggest that some of these plants and their constituent compounds have inhibitory activity on coronaviruses. Numerous medicinal plants, their extracts, and secondary metabolites have been investigated over a period of time for antiviral activity. Among them, kaempferol, silybin, myricitrin, licoleafol, and curcumin are promising agents with potential activity against SARS-CoV-2. Natural compounds can form strong bonds with the active sites of SARS-CoV-2 protease. Structural and non-structural SARS-CoV-2 proteins such as Spike protein, PLpro, and 3CLpro are inhibited by these phytochemicals.

Conclusion: Prospective treatments targeted at the life cycle stages of the virus may eventuate from research endeavors, and it must not be discounted that therapy originally derived from plant secondary metabolite sources may potentially have a part to play.

Keywords: Coronavirus disease 2019 (COVID-19), SARS-CoV-2, secondary metabolites, medicinal plants, natural compounds, phytochemicals.

« Previous Next »
[1]
Schoeman D, Fielding BC. Coronavirus envelope protein: Current knowledge. Virol J 2019; 16(1): 69.
[http://dx.doi.org/10.1186/s12985-019-1182-0] [PMID: 31133031]
[2]
Lai MMC, Holmes KV. Coronaviridae: The viruses and their replication Fields Virology. 4th ed. Philadelphia: Lippincott, Williams & Wilkins 2001; pp. 1163-85.
[3]
Masters PS. The molecular biology of coronaviruses. Adv Virus Res 2006; 66: 193-292.
[http://dx.doi.org/10.1016/S0065-3527(06)66005-3] [PMID: 16877062]
[4]
Su S, Wong G, Shi W, et al. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol 2016; 24(6): 490-502.
[http://dx.doi.org/10.1016/j.tim.2016.03.003] [PMID: 27012512]
[5]
Lai MM, Cavanagh D. The molecular biology of coronaviruses. Adv Virus Res 1997; 48: 1-100.
[http://dx.doi.org/10.1016/S0065-3527(08)60286-9] [PMID: 9233431]
[6]
Wong LY, Lui PY, Jin DY. A molecular arms race between host innate antiviral response and emerging human coronaviruses. Virol Sin 2016; 31(1): 12-23.
[http://dx.doi.org/10.1007/s12250-015-3683-3] [PMID: 26786772]
[7]
Chan JFW, Kok KH, Zhu Z, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect 2020; 9(1): 221-36.
[http://dx.doi.org/10.1080/22221751.2020.1719902] [PMID: 31987001]
[8]
Ye ZW, Yuan S, Yuen KS, Fung SY, Chan CP, Jin DY. Zoonotic origins of human coronaviruses. Int J Biol Sci 2020; 16(10): 1686-97.
[http://dx.doi.org/10.7150/ijbs.45472] [PMID: 32226286]
[9]
Peiris JS, Guan Y, Yuen KY. Severe acute respiratory syndrome. Nat Med 2004; 10(12): S88-97.
[http://dx.doi.org/10.1038/nm1143] [PMID: 15577937]
[10]
Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012; 367(19): 1814-20.
[http://dx.doi.org/10.1056/NEJMoa1211721] [PMID: 23075143]
[11]
Jiang S, Shi Z, Shu Y, et al. A distinct name is needed for the new coronavirus. Lancet 2020; 395: 949.
[http://dx.doi.org/10.1016/S0140-6736(20)30419-0]
[12]
Guarner J. Three emerging coronaviruses in two decades the story of SARS, MERS, and now COVID-19. Am J Clin Pathol 2020; 153(4): 420-1.
[http://dx.doi.org/10.1093/ajcp/aqaa029] [PMID: 32053148]
[13]
Gorbalenya AE, Baker SC, Baric RS, et al. Severe acute respiratory syndrome-related coronavirus–the species and its viruses, a statement of the coronavirus study group. BioRxiv 2020.
[http://dx.doi.org/10.1101/2020.02.07.937862]
[14]
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395(10223): 497-506.
[http://dx.doi.org/10.1016/S0140-6736(20)30183-5] [PMID: 31986264]
[15]
Heymann DL, Shindo N. COVID-19: What is next for public health? Lancet 2020; 395(10224): 542-5.
[http://dx.doi.org/10.1016/S0140-6736(20)30374-3] [PMID: 32061313]
[16]
Centers for Disease Control and Prevention (CDC) 2019. Available from: https://www.cdc.gov/coronavirus/2019-ncov/index.html
[17]
Kim JH, Marks F, Clemens JD. Looking beyond COVID-19 vaccine phase 3 trials. Nat Med 2021; 27: 205-11.
[18]
Drexler JF, Corman VM, Drosten C. Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS. Antiviral Res 2014; 101: 45-56.
[http://dx.doi.org/10.1016/j.antiviral.2013.10.013] [PMID: 24184128]
[19]
Ganjhu RK, Mudgal PP, Maity H, et al. Herbal plants and plant preparations as remedial approach for viral diseases. Virusdisease 2015; 26(4): 225-36.
[http://dx.doi.org/10.1007/s13337-015-0276-6] [PMID: 26645032]
[20]
Cushnie TPT, Lamb AJ. Antimicrobial activity of flavonoids. Int J Antimicrob Agents 2005; 26(5): 343-56.
[http://dx.doi.org/10.1016/j.ijantimicag.2005.09.002] [PMID: 16323269]
[21]
Amoros M, Simões CMO, Girre L, Sauvager F, Cormier M. Synergistic effect of flavones and flavonols against herpes simplex virus type 1 in cell culture. Comparison with the antiviral activity of propolis. J Nat Prod 1992; 55(12): 1732-40.
[http://dx.doi.org/10.1021/np50090a003] [PMID: 1338212]
[22]
Schwarz S, Sauter D, Wang K, et al. Kaempferol derivatives as antiviral drugs against the 3a channel protein of coronavirus. Planta Med 2014; 80(2-3): 177-82.
[http://dx.doi.org/10.1055/s-0033-1360277] [PMID: 24458263]
[23]
Chen AY, Chen YC, Chen YC. A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention. Food Chem 2013; 138(4): 2099-107.
[http://dx.doi.org/10.1016/j.foodchem.2012.11.139] [PMID: 23497863]
[24]
Middleton E Jr, Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer. Pharmacol Rev 2000; 52(4): 673-751.
[PMID: 11121513]
[25]
Zakaryan H, Arabyan E, Oo A, Zandi K. Flavonoids: Promising natural compounds against viral infections. Arch Virol 2017; 162(9): 2539-51.
[http://dx.doi.org/10.1007/s00705-017-3417-y] [PMID: 28547385]
[26]
Somerset SM, Johannot L. Dietary flavonoid sources in Australian adults. Nutr Cancer 2008; 60(4): 442-9.
[http://dx.doi.org/10.1080/01635580802143836] [PMID: 18584477]
[27]
Ha SY, Youn H, Song CS, et al. Antiviral effect of flavonol glycosides isolated from the leaf of Zanthoxylum piperitum on influenza virus. J Microbiol 2014; 52(4): 340-4.
[http://dx.doi.org/10.1007/s12275-014-4073-5] [PMID: 24682996]
[28]
Thiel V, Ivanov KA, Putics Á, et al. Mechanisms and enzymes involved in SARS Coronavirus genome expression. J Gen Virol 2003; 84(Pt 9): 2305-15.
[http://dx.doi.org/10.1099/vir.0.19424-0] [PMID: 12917450]
[29]
Grum-Tokars V, Ratia K, Begaye A, Baker SC, Mesecar AD. Evaluating the 3C-like protease activity of SARS-Coronavirus: Recommendations for standardized assays for drug discovery. Virus Res 2008; 133(1): 63-73.
[http://dx.doi.org/10.1016/j.virusres.2007.02.015] [PMID: 17397958]
[30]
Lee H, Mittal A, Patel K, et al. Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual and high-throughput screenings. Bioorg Med Chem 2014; 22(1): 167-77.
[http://dx.doi.org/10.1016/j.bmc.2013.11.041] [PMID: 24332657]
[31]
Tahir Ul Qamar M, Alqahtani SM, Alamri MA, Chen LL. Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants. J Pharm Anal 2020; 10(4): 313-9.
[http://dx.doi.org/10.1016/j.jpha.2020.03.009] [PMID: 32296570]
[32]
Jo S, Kim S, Shin DH, Kim MS. Inhibition of SARS-CoV 3CL protease by flavonoids. J Enzyme Inhib Med Chem 2020; 35(1): 145-51.
[http://dx.doi.org/10.1080/14756366.2019.1690480] [PMID: 31724441]
[33]
Fan W, Qian S, Qian P, Li X. Antiviral activity of luteolin against Japanese encephalitis virus. Virus Res 2016; 220: 112-6.
[http://dx.doi.org/10.1016/j.virusres.2016.04.021] [PMID: 27126774]
[34]
Murali KS, Sivasubramanian S, Vincent S, et al. Anti-chikungunya activity of luteolin and apigenin rich fraction from Cynodon dactylon. Asian Pac J Trop Med 2015; 8(5): 352-8.
[http://dx.doi.org/10.1016/S1995-7645(14)60343-6] [PMID: 26003593]
[35]
Knipping K, Garssen J, van’t Land B. An evaluation of the inhibitory effects against rotavirus infection of edible plant extracts. Virol J 2012; 9: 137.
[http://dx.doi.org/10.1186/1743-422X-9-137] [PMID: 22834653]
[36]
Yi L, Li Z, Yuan K, et al. Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells. J Virol 2004; 78(20): 11334-9.
[http://dx.doi.org/10.1128/JVI.78.20.11334-11339.2004] [PMID: 15452254]
[37]
Yu MS, Lee J, Lee JM, et al. Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13. Bioorg Med Chem Lett 2012; 22(12): 4049-54.
[http://dx.doi.org/10.1016/j.bmcl.2012.04.081] [PMID: 22578462]
[38]
Yang L, Lin J, Zhou B, Liu Y, Zhu B. Activity of compounds from Taxillus sutchuenensis as inhibitors of HCV NS3 serine protease. Nat Prod Res 2017; 31(4): 487-91.
[http://dx.doi.org/10.1080/14786419.2016.1190719] [PMID: 27295355]
[39]
Jucá MM, Cysne Filho FMS, de Almeida JC, et al. Flavonoids: Biological activities and therapeutic potential. Nat Prod Res 2018; 16: 1-14.
[http://dx.doi.org/10.1080/14786419.2018.1493588] [PMID: 30445839]
[40]
Frabasile S, Koishi AC, Kuczera D, et al. The citrus flavanone naringenin impairs dengue virus replication in human cells. Sci Rep 2017; 7: 41864.
[http://dx.doi.org/10.1038/srep41864] [PMID: 28157234]
[41]
Kiat TS, Pippen R, Yusof R, Ibrahim H, Khalid N, Rahman NA. Inhibitory activity of cyclohexenyl chalcone derivatives and flavonoids of fingerroot, Boesenbergia rotunda (L.), towards dengue-2 virus NS3 protease. Bioorg Med Chem Lett 2006; 16(12): 3337-40.
[http://dx.doi.org/10.1016/j.bmcl.2005.12.075] [PMID: 16621533]
[42]
Malekmohammad K, Rafieian-Kopaei M, Sardari S, Sewell RDE. Effective antiviral medicinal plants and biological compounds against central nervous system infections: A mechanistic review. Curr Drug Discov Technol 2020; 17(4): 469-83.
[http://dx.doi.org/10.2174/1570163816666190715114741] [PMID: 31309894]
[43]
Sardari S, Rafieian-Kopaei M, Malekmohammad K, Sewell RDE. Review of phytochemical compounds as antiviral agents against arboviruses from the genera flavivirus and alphavirus. Curr Drug Discov Technol 2020; 17(4): 484-97.
[http://dx.doi.org/10.2174/1570163817666200122102443] [PMID: 31969106]
[44]
Mohammadi N, Shaghaghi N. Inhibitory effect of eight secondary metabolites from conventional medicinal plants on COVID-19 virus protease by molecular docking analysis. Chemrxiv 2020.
[http://dx.doi.org/10.26434/chemrxiv.11987475]
[45]
Schwarz S, Wang K, Yu W, Sun B, Schwarz W. Emodin inhibits current through SARS-associated coronavirus 3a protein. Antiviral Res 2011; 90(1): 64-9.
[http://dx.doi.org/10.1016/j.antiviral.2011.02.008] [PMID: 21356245]
[46]
Lu W, Zheng BJ, Xu K, et al. Severe acute respiratory syndrome-associated coronavirus 3a protein forms an ion channel and modulates virus release. Proc Natl Acad Sci USA 2006; 103(33): 12540-5.
[http://dx.doi.org/10.1073/pnas.0605402103] [PMID: 16894145]
[47]
Ho TY, Wu SL, Chen JC, Li CC, Hsiang CY. Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction. Antiviral Res 2007; 74(2): 92-101.
[http://dx.doi.org/10.1016/j.antiviral.2006.04.014] [PMID: 16730806]
[48]
Cong Y, Hart BJ, Gross R, et al. MERS-CoV pathogenesis and antiviral efficacy of licensed drugs in human monocyte-derived antigen-presenting cells. PLoS One 2018; 13(3): e0194868.
[http://dx.doi.org/10.1371/journal.pone.0194868] [PMID: 29566060]
[49]
Dyall J, Coleman CM, Hart BJ, et al. Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection. Antimicrob Agents Chemother 2014; 58(8): 4885-93.
[http://dx.doi.org/10.1128/AAC.03036-14] [PMID: 24841273]
[50]
Zhou Y, Hou Y, Shen J, Huang Y, Martin W, Cheng F. Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. Cell Discov 2020; 6: 14.
[http://dx.doi.org/10.1038/s41421-020-0153-3] [PMID: 32194980]
[51]
Vimalanathan S, Ignacimuthu S, Hudson J. Medicinal plants of Tamil Nadu (southern India) are a rich source of antiviral activities. Pharm Biol 2009; 47: 422-9.
[http://dx.doi.org/10.1080/13880200902800196]
[52]
Alam G, Wahyuono S, Ganjar IG, Hakim L, Timmerman H, Verpoorte R. Tracheospasmolytic activity of viteosin-A and vitexicarpin isolated from Vitex trifolia. Planta Med 2002; 68(11): 1047-9.
[http://dx.doi.org/10.1055/s-2002-35650] [PMID: 12451502]
[53]
Srivastava RAK, Mistry S, Sharma S. A novel anti-inflammatory natural product from Sphaeranthus indicus inhibits expression of VCAM1 and ICAM1, and slows atherosclerosis progression independent of lipid changes. Nutr Metab 2015; 12: 20.
[http://dx.doi.org/10.1186/s12986-015-0018-1] [PMID: 26064179]
[54]
Fiore C, Eisenhut M, Krausse R, et al. Antiviral effects of Glycyrrhiza species. Phytother Res 2008; 22(2): 141-8.
[http://dx.doi.org/10.1002/ptr.2295] [PMID: 17886224]
[55]
Maity N, Nema NK, Sarkar BK, Mukherjee PK. Standardized Clitoria ternatea leaf extract as hyaluronidase, elastase and matrix-metalloproteinase-1 inhibitor. Indian J Pharmacol 2012; 44(5): 584-7.
[http://dx.doi.org/10.4103/0253-7613.100381] [PMID: 23112418]
[56]
Li W, Moore MJ, Vasilieva N, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003; 426(6965): 450-4.
[http://dx.doi.org/10.1038/nature02145] [PMID: 14647384]
[57]
Keyaerts E, Vijgen L, Pannecouque C, et al. Plant lectins are potent inhibitors of coronaviruses by interfering with two targets in the viral replication cycle. Antiviral Res 2007; 75(3): 179-87.
[http://dx.doi.org/10.1016/j.antiviral.2007.03.003] [PMID: 17428553]
[58]
Olivieri F, Prasad V, Valbonesi P, et al. A systemic antiviral resistance-inducing protein isolated from Clerodendrum inerme Gaertn. is a polynucleotide:adenosine glycosidase (ribosome-inactivating protein). FEBS Lett 1996; 396(2-3): 132-4.
[http://dx.doi.org/10.1016/0014-5793(96)01089-7] [PMID: 8914973]
[59]
Tsai YC, Lee CL, Yen HR, et al. Antiviral action of tryptanthrin isolated from Strobilanthes cusia leaf against human coronavirus NL63. Biomolecules 2020; 10(3): 366.
[http://dx.doi.org/10.3390/biom10030366] [PMID: 32120929]
[60]
Hussain F, Jahan N, Rahman KU, Sultana B, Jamil S. Identification of hypotensive biofunctional compounds of Coriandrum sativum and evaluation of their angiotensin-converting enzyme (ACE) inhibition potential. Oxid Med Cell Longev 2018; 2018: 4643736.
[http://dx.doi.org/10.1155/2018/4643736] [PMID: 30581531]
[61]
Prathapan A, Vineetha VP, Abhilash PA, Raghu KG. Boerhaavia diffusa L. attenuates angiotensin II-induced hypertrophy in H9c2 cardiac myoblast cells via modulating oxidative stress and down-regulating NF-κβ and transforming growth factor β1. Br J Nutr 2013; 110(7): 1201-10.
[http://dx.doi.org/10.1017/S0007114513000561] [PMID: 23591029]
[62]
Khan MY, Kumar V. Mechanism & inhibition kinetics of bioassay-guided fractions of Indian medicinal plants and foods as ACE inhibitors. J Tradit Complement Med 2018; 9(1): 73-84.
[http://dx.doi.org/10.1016/j.jtcme.2018.02.001] [PMID: 30671369]
[63]
Ismail T, Sestili P, Akhtar S. Pomegranate peel and fruit extracts: A review of potential anti-inflammatory and anti-infective effects. J Ethnopharmacol 2012; 143(2): 397-405.
[http://dx.doi.org/10.1016/j.jep.2012.07.004] [PMID: 22820239]
[64]
Albarri O, Var I, Boushihassal A, et al. The potential effects of pomegranate on bacteria and viruses: A review. J Biotechnol Sci Res 2016; 3(6): 175-80.
[65]
Moradi MT, Karimi A, Shahrani M, Hashemi L, Ghaffari-Goosheh MS. Anti-influenza virus activity and phenolic content of Pomegranate (Punica granatum L.) peel extract and fractions. Avicenna J Med Biotechnol 2019; 11(4): 285-91.
[PMID: 31908736]
[66]
Liu CH, Jassey A, Hsu H-Y, Lin L-T. Antiviral activities of Silymarin and derivatives. Molecules 2019; 24(8): 1552.
[http://dx.doi.org/10.3390/molecules24081552] [PMID: 31010179]
[67]
Pandit M, Latha N. In silico studies reveal potential antiviral activity of phytochemicals from medicinal plants for the treatment of COVID-19 infection. Research Square 2020.
[http://dx.doi.org/10.21203/rs.3.rs-22687/v1]
[68]
Arora R, Chawla R, Marwah R, et al. Potential of complementary and alternative medicine in preventive management of novel H1N1 flu (Swine flu) pandemic: Thwarting potential disasters in the bud. Evid Based Complement Alternat Med 2011; 2011: 586506.
[http://dx.doi.org/10.1155/2011/586506] [PMID: 20976081]
[69]
Coon JT, Ernst E. Andrographis paniculata in the treatment of upper respiratory tract infections: A systematic review of safety and efficacy. Planta Med 2004; 70(4): 293-8.
[http://dx.doi.org/10.1055/s-2004-818938] [PMID: 15095142]
[70]
Yarnell E. Herbs for viral respiratory infections. Altern Complement Ther 2018; 24: 35-43.
[http://dx.doi.org/10.1089/act.2017.29150.eya]
[71]
Liu YT, Chen HW, Lii CK, et al. A diterpenoid, 14-deoxy-11, 12-didehydroandrographolide, in Andrographis paniculata reduces steatohepatitis and liver injury in mice fed a high-fat and high cholesterol diet. Nutrients 2020; 12(2): 523.
[http://dx.doi.org/10.3390/nu12020523] [PMID: 32085637]
[72]
Conti P, Ronconi G, Caraffa A, et al. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): Anti-inflammatory strategies. J Biol Regul Homeost Agents 2020; 34(2): 327-31.
[http://dx.doi.org/10.23812/CONTI-E] [PMID: 32171193]
[73]
Zhao C, Zhao W. NLRP3 Inflammasome - A key player in antiviral responses. Front Immunol 2020; 11: 211.
[http://dx.doi.org/10.3389/fimmu.2020.00211] [PMID: 32133002]
[74]
He L, Qi Y, Rong X, et al. The Ayurvedic medicine Salacia oblonga attenuates diabetic renal fibrosis in rats: Suppression of angiotensin II/AT1 signaling. Evid Based Complement Alternat Med 2011; 2011: 807451.
[http://dx.doi.org/10.1093/ecam/nep095] [PMID: 19706694]
[75]
Liu Y, Yang Y, Zhang C, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci 2020; 63(3): 364-74.
[http://dx.doi.org/10.1007/s11427-020-1643-8] [PMID: 32048163]
[76]
Kusumoto IT, Nakabayashi T, Kida H, et al. Screening of various plant extracts used in Ayurvedic medicine for inhibitory effects on human immunodeficiency virus type 1 (HIV-1) protease. Phytother Res 1995; 9: 180-4.
[http://dx.doi.org/10.1002/ptr.2650090305]
[77]
Shanti BM. Perspective of potential plants for medicine from Rajasthan, India. Int J Pharm Res 2016; 7(1): 1-6.
[78]
Awaad AS, Alothman MR, Zain YM, et al. Comparative nutritional value and antimicrobial activities between three Euphorbia species growing in Saudi Arabia. Saudi Pharm J 2017; 25(8): 1226-30.
[http://dx.doi.org/10.1016/j.jsps.2017.09.007] [PMID: 29204072]
[79]
Rege A, Chowdhary AS. Evaluation of Ocimum sanctum and Tinospora cordifolia as probable HIV protease inhibitors. Int J Pharm Sci Rev Res 2014; 25(1): 315-8.
[80]
Yu YB. The extracts of Solanum nigrum L. for inhibitory effects on HIV-1 and its essential enzymes. Korean J Orient Med 2004; 10: 119-26.
[81]
Thayil Seema M, Thyagarajan S. Methanol and aqueous extracts of Ocimum kilimandscharicum (Karpuratulasi) inhibits HIV-1 reverse transcriptase in vitro. Int J Pharmacogn Phytochem Res 2016; 8: 1099-103.
[82]
Nair R. HIV-1 reverse transcriptase inhibition by Vitex negundo L. leaf extract and quantification of flavonoids in relation to anti-HIV activity. J Cell Mol Biol 2012; 10: 53-9.
[83]
Buonaguro L, Tagliamonte M, Tornesello ML, Buonaguro FM. SARS-CoV-2 RNA polymerase as target for antiviral therapy. J Transl Med 2020; 18(1): 185.
[http://dx.doi.org/10.1186/s12967-020-02355-3] [PMID: 32370758]
[84]
Bliah MAM. Methods and compositions for inhibiting the infectious activity of viruses. US patent 4,742,046, 1988.
[85]
Krawitz C, Mraheil MA, Stein M, et al. Inhibitory activity of a standardized elderberry liquid extract against clinically-relevant human respiratory bacterial pathogens and influenza A and B viruses. BMC Complement Altern Med 2011; 11: 16.
[http://dx.doi.org/10.1186/1472-6882-11-16] [PMID: 21352539]
[86]
Zhou P, Yang X-L, Wang X-G, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579(7798): 270-3.
[http://dx.doi.org/10.1038/s41586-020-2012-7] [PMID: 32015507]
[87]
Elsebai MF, Mocan A, Atanasov AG. Cynaropicrin: A comprehensive research review and therapeutic potential as an anti-hepatitis C virus agent. Front Pharmacol 2016; 7: 472.
[http://dx.doi.org/10.3389/fphar.2016.00472] [PMID: 28008316]
[88]
Lunavath V. Estari. Inhibition of Human Immunodeficiency Virus (HIV-1) reverse transcriptase by Casia occidentalis (L) plant extract. Int J Engine Res 2012; 3(7): 490-3.
[89]
Weber ND, Andersen DO, North JA, Murray BK, Lawson LD, Hughes BG. In vitro virucidal effects of Allium sativum (garlic) extract and compounds. Planta Med 1992; 58(5): 417-23.
[http://dx.doi.org/10.1055/s-2006-961504] [PMID: 1470664]
[90]
Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr HW. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet 2003; 361(9374): 2045-6.
[http://dx.doi.org/10.1016/S0140-6736(03)13615-X] [PMID: 12814717]
[91]
Wu A, Peng Y, Huang B, et al. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe 2020; 27(3): 325-8.
[http://dx.doi.org/10.1016/j.chom.2020.02.001] [PMID: 32035028]
[92]
Patel B, Sharma S, Nair N, Majeed J, Goyal RK, Dhobi M. Therapeutic opportunities of edible antiviral plants for COVID-19. Mol Cell Biochem 2021; 476(6): 2345-64.
[http://dx.doi.org/10.1007/s11010-021-04084-7] [PMID: 33587232]
[93]
Chowdhury M, Shahid M, Kashem M. Scope of natural plant extract to deactivate COVID-19. 2020.
[http://dx.doi.org/10.21203/rs.3.rs-19240/v1]
[94]
Meneguzzo F, Ciriminna R, Zabini F, Pagliaro M. Review of evidence available on hesperidin-rich products as potential tools against COVID-19 and hydrodynamic cavitation-based extraction as a method of increasing their production. Processes 2020; 8: 549.
[http://dx.doi.org/10.3390/pr8050549]
[95]
Park JY, Ko JA, Kim DW, et al. Chalcones isolated from Angelica keiskei inhibit cysteine proteases of SARS-CoV. J Enzyme Inhib Med Chem 2016; 31(1): 23-30.
[http://dx.doi.org/10.3109/14756366.2014.1003215] [PMID: 25683083]
[96]
Park JY, Jeong HJ, Kim JH, et al. Diarylheptanoids from Alnus japonica inhibit papain-like protease of severe acute respiratory syndrome coronavirus. Biol Pharm Bull 2012; 35(11): 2036-42.
[http://dx.doi.org/10.1248/bpb.b12-00623] [PMID: 22971649]
[97]
Park JY, Kim JH, Kim YM, et al. Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases. Bioorg Med Chem 2012; 20(19): 5928-35.
[http://dx.doi.org/10.1016/j.bmc.2012.07.038] [PMID: 22884354]
[98]
Park JY, Yuk HJ, Ryu HW, et al. Evaluation of polyphenols from Broussonetia papyrifera as coronavirus protease inhibitors. J Enzyme Inhib Med Chem 2017; 32(1): 504-15.
[http://dx.doi.org/10.1080/14756366.2016.1265519] [PMID: 28112000]
[99]
Gentile D, Patamia V, Scala A, Sciortino MT, Piperno A, Rescifina A. Putative inhibitors of SARS-CoV-2 main protease from a library of marine natural products: A virtual screening and molecular modeling study. Mar Drugs 2020; 18(4): 225.
[http://dx.doi.org/10.3390/md18040225] [PMID: 32340389]
[100]
Singh R, Gautam A, Chandel S, et al. Protease inhibitory effect of natural polyphenolic compounds on SARS-CoV-2: An In silico study. Molecules 2020; 25(20): 4604.
[http://dx.doi.org/10.3390/molecules25204604] [PMID: 33050360]
[101]
Letko M, Marzi A, Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol 2020; 5(4): 562-9.
[http://dx.doi.org/10.1038/s41564-020-0688-y] [PMID: 32094589]
[102]
Yamamoto M, Matsuyama S, Li X, et al. Identification of nafamostat as a potent inhibitor of middle East respiratory syndrome coronavirus S protein-mediated membrane fusion using the split-protein-based cell-cell fusion assay. Antimicrob Agents Chemother 2016; 60(11): 6532-9.
[http://dx.doi.org/10.1128/AAC.01043-16] [PMID: 27550352]
[103]
Zhou H, Fang Y, Xu T, Ni WJ, Shen AZ, Meng XM. Potential therapeutic targets and promising drugs for combating SARS-CoV-2. Br J Pharmacol 2020; 177(14): 3147-61.
[http://dx.doi.org/10.1111/bph.15092] [PMID: 32368792]
[104]
Kadioglu O, Nass J, Saeed MEM, Schuler B, Efferth T. Kaempferol is an anti-inflammatory compound with activity towards NF-κB pathway proteins. Anticancer Res 2015; 35(5): 2645-50.
[PMID: 25964540]
[105]
Swarnalatha S, Umamaheswari A, Puratchikody A. Immunomodulatory activity of kaempferol 5-O-β-d-glucopyranoside from Indigofera aspalathoides Vahl ex DC. (Papilionaceae). Med Chem Res 2015; 24(7): 2889-97.
[http://dx.doi.org/10.1007/s00044-015-1341-9]
[106]
Li X, Xie P, Hou Y, et al. Tangeretin inhibits oxidative stress and inflammation via upregulating Nrf-2 signaling pathway in collagen-induced arthritic rats. Pharmacology 2019; 104(3-4): 187-95.
[http://dx.doi.org/10.1159/000501163] [PMID: 31344704]
[107]
Kou X, Wang X, Ji R, et al. Occurrence, biological activity and metabolism of 6-shogaol. Food Funct 2018; 9(3): 1310-27.
[http://dx.doi.org/10.1039/C7FO01354J] [PMID: 29417118]
[108]
Tallei ET, Geiner Tumilaar S, et al. Potential of plant bioactive compounds as SARS-CoV-2 Main Protease (Mpro) and Spike (S) glycoprotein inhibitors: A molecular docking study. Scientifica 2020; 2020: 6307457.
[http://dx.doi.org/10.1155/2020/6307457]
[109]
Ubani A, Agwom F, Shehu NY, et al. Molecular docking analysis of some phytochemicals on two SARS-CoV-2 targets. bioRxiv 2020.
[http://dx.doi.org/10.1101/2020.03.31.017657]
[110]
Jena AB, Kanungo N, Nayak V, Chainy GBN, Dandapat J. Catechin and curcumin interact with S protein of SARS-CoV2 and ACE2 of human cell membrane: Insights from computational studies. Sci Rep 2021; 11(1): 2043.
[http://dx.doi.org/10.1038/s41598-021-81462-7] [PMID: 33479401]
[111]
Cyranoski D. Profile of a killer: The complex biology powering the coronavirus pandemic. Nature 2020; 581(7806): 22-6.
[http://dx.doi.org/10.1038/d41586-020-01315-7] [PMID: 32367025]
[112]
Hussein G, Miyashiro H, Nakamura N, et al. Inhibitory effects of Sudanese plant extracts on HIV-1 replication and HIV-1 protease. Phytother Res 1999; 13(1): 31-6.
[http://dx.doi.org/10.1002/(SICI)1099-1573(199902)13:1<31:AID-PTR381>3.0.CO;2-C] [PMID: 10189947]
[113]
Donma MM, Donma O. The effects of allium sativum on immunity within the scope of COVID-19 infection. Med Hypotheses 2020; 144: 109934.
[http://dx.doi.org/10.1016/j.mehy.2020.109934] [PMID: 32512493]
[114]
Thuy BTP, My TTA, Hai NTT, et al. Investigation into SARS-CoV-2 resistance of compounds in garlic essential oil. ACS Omega 2020; 5(14): 8312-20.
[http://dx.doi.org/10.1021/acsomega.0c00772] [PMID: 32363255]
[115]
Akamatsu H, Komura J, Asada Y, Niwa Y. Mechanism of anti-inflammatory action of glycyrrhizin: Effect on neutrophil functions including reactive oxygen species generation. Planta Med 1991; 57(2): 119-21.
[http://dx.doi.org/10.1055/s-2006-960045] [PMID: 1891493]
[116]
Arun LB, Arunachalam AM, Arunachalam KD, Annamalai SK, Kumar KA. In vivo anti-ulcer, anti-stress, anti-allergic, and functional properties of gymnemic acid isolated from Gymnema sylvestre R Br. BMC Complement Altern Med 2014; 14: 70.
[http://dx.doi.org/10.1186/1472-6882-14-70] [PMID: 24559073]
[117]
Gilani AH, Khan AU, Raoof M, et al. Gastrointestinal, selective airways and urinary bladder relaxant effects of Hyoscyamus niger are mediated through dual blockade of muscarinic receptors and Ca2+ channels. Fundam Clin Pharmacol 2008; 22(1): 87-99.
[http://dx.doi.org/10.1111/j.1472-8206.2007.00561.x] [PMID: 18251725]
[118]
Behravan M, Vaezi-Kakhki MR, Baharshahi A. Comparing larvicidal effect of methanol extract of the aerial parts of Henbane (Hyoscyamus niger L.) and Oleander (Nerium oleander L.) plants on Anopheles spp Larvae (Diptera: Culicidae) in vitro. Zahedan J Res Med Sci 2017; 19(3): e8631.
[http://dx.doi.org/10.5812/zjrms.8631]
[119]
Jimenez P, Cabrero P, Basterrechea JE, et al. Effects of short-term heating on total polyphenols, anthocyanins, antioxidant activity and lectins of different parts of dwarf elder (Sambucus ebulus L.). Plant Foods Hum Nutr 2014; 69(2): 168-74.
[http://dx.doi.org/10.1007/s11130-014-0417-x] [PMID: 24793353]
[120]
Galani VJ, Patel BG, Rana DG. Sphaeranthus indicus Linn.: A phytopharmacological review. Int J Ayurveda Res 2010; 1(4): 247-53.
[http://dx.doi.org/10.4103/0974-7788.76790] [PMID: 21455454]
[121]
Tiwari BK, Khosa RL. Hepatoprotective and antioxidant effect of Sphaeranthus indicus against acetaminophen-induced hepatotoxicity in rats. J Pharm Sci Res 2009; 1: 26-30.
[122]
Sharma N, Muthamilarasan M, Prasad A, Prasad M. Genomics approaches to synthesize plant-based biomolecules for therapeutic applications to combat SARS-CoV-2. Genomics 2020; 112(6): 4322-31.
[http://dx.doi.org/10.1016/j.ygeno.2020.07.033] [PMID: 32717321]

Rights & Permissions Print Cite
Article Metrics
10
1
© 2024 Bentham Science Publishers | Privacy Policy